HIF1A and neoplasm: Instead, tramadol-treated cells showed reduced migratory and metastatic potential [19], implying that HIF-1α activation alone is insufficient to drive tumor progression and may be counterbalanced by other tramadol-mediated effects, such as cell-cycle arrest and apoptosis induction.